Grifols (GIFLF) Exchange Rate Effect (2010 - 2025)
Grifols' (GIFLF) quarterly Exchange Rate Effect came in at -$109.4 million in Q4 2025, down 565.44% on a YoY basis from $23.5 million in Q4 2024, and down 565.44% quarter-over-quarter from $23.5 million in Q4 2024.
Analysis
Grifols (GIFLF) Exchange Rate Effect (2010 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Exchange Rate Effect for 14 consecutive years, with -$109.4 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect fell 565.44% year-over-year to -$109.4 million; the trailing twelve-month figure through Dec 2025 stood at -$86.9 million (down 208.78% YoY), and the FY2025 full-year result was -$106.2 million, down 551.75% from the prior year.
- Exchange Rate Effect retreated to -$109.4 million in Q4 2025 per GIFLF's latest filing, from $23.5 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $23.5 million in Q4 2024 and bottomed at -$109.4 million in Q4 2025.
- Historically, Exchange Rate Effect has averaged -$34.0 million across 3 years, with a median of -$16.1 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect jumped 245.67% in 2024, then slumped 565.44% in 2025.
- Over 3 years, Exchange Rate Effect stood at -$16.1 million in 2023, then surged by 245.67% to $23.5 million in 2024, then plunged by 565.44% to -$109.4 million in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$109.4 million, $23.5 million, and -$16.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | 315,000.00 |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | -109.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -109.42 Mn |
| Dec 31, 2024 | 23.51 Mn |
| Dec 31, 2023 | -16.14 Mn |
| Mar 31, 2020 | 15.12 Mn |
| Dec 31, 2019 | 57.43 Mn |
| Mar 31, 2019 | 22.27 Mn |
| Dec 31, 2018 | 33.48 Mn |
| Jun 30, 2018 | 54.75 Mn |
| Mar 31, 2018 | -27.72 Mn |
| Dec 31, 2017 | -102.07 Mn |
| Jun 30, 2017 | -79.63 Mn |
| Mar 31, 2017 | 11.32 Mn |
| Dec 31, 2016 | 66.14 Mn |
| Sep 30, 2016 | -51.23 Mn |
| Jun 30, 2016 | 86.73 Mn |
| Dec 31, 2015 | 901,008.40 |
| Sep 30, 2015 | -3.90 Mn |
| Jun 30, 2015 | 124.23 Mn |
| Mar 31, 2015 | 143.83 Mn |
| Dec 31, 2014 | 1.51 Mn |